Literature DB >> 19556914

Retrospective analysis of histopathologic prognostic factors after hepatectomy for intrahepatic cholangiocarcinoma.

Bei-Ge Jiang1, Liang-Liang Sun, Wen-Long Yu, Zhao-Hui Tang, Ming Zong, Yong-Jie Zhang.   

Abstract

BACKGROUND: The aim of this study was to investigate histopathologic prognostic factors in patients with intrahepatic cholangiocarcinoma (ICC) whose tumors were resected to determine the optimal surgical strategies.
METHODS: One hundred and two ICC patients who underwent laparotomy from July 1998 to December 2000 were followed up successfully. Histopathologic variables were selected for univariate and multivariate analyses to evaluate their influence on the outcome.
RESULTS: The 1-, 3-, and 5-year survival rates after surgery were 56.9%, 25.5%, and 16.9%, respectively. The average survival duration was 21.91 +/- 20.17 months. In univariate analysis, the presence of lymph node (LN) metastasis, number of LNs with metastases, presence of intrahepatic metastasis, curative resection, and TNM stage were significant risk factors for survival. Multivariate analysis revealed that intrahepatic metastasis, noncurative resection, and TNM stage IVa were independent prognostic factors.
CONCLUSIONS: The histopathologic characteristics of intrahepatic metastasis were closely related to poor prognosis in ICC patients. Extensive hepatectomy with LN dissection may offer the only chance for long-term survival in patients with ICC.

Entities:  

Mesh:

Year:  2009        PMID: 19556914     DOI: 10.1097/PPO.0b013e31819e3312

Source DB:  PubMed          Journal:  Cancer J        ISSN: 1528-9117            Impact factor:   3.360


  7 in total

1.  Predicting IDH mutation status of intrahepatic cholangiocarcinomas based on contrast-enhanced CT features.

Authors:  Yong Zhu; Jun Chen; Weiwei Kong; Liang Mao; Wentao Kong; Qun Zhou; Zhengyang Zhou; Bin Zhu; Zhongqiu Wang; Jian He; Yudong Qiu
Journal:  Eur Radiol       Date:  2017-07-27       Impact factor: 5.315

2.  Clinical parameters predicting survival duration after hepatectomy for intrahepatic cholangiocarcinoma.

Authors:  Bei-ge Jiang; Rui-liang Ge; Liang-liang Sun; Ming Zong; Gong-tian Wei; Yong-jie Zhang
Journal:  Can J Gastroenterol       Date:  2011-11       Impact factor: 3.522

3.  Surgical treatment of intrahepatic cholangiocarcinoma: outcomes and predictive factors.

Authors:  Michelle C Ellis; Maria A Cassera; John T Vetto; Susan L Orloff; Paul D Hansen; Kevin G Billingsley
Journal:  HPB (Oxford)       Date:  2010-12-03       Impact factor: 3.647

Review 4.  Novel approaches in search for biomarkers of cholangiocarcinoma.

Authors:  Lavinia-Patricia Mocan; Maria Ilieș; Carmen Stanca Melincovici; Mihaela Spârchez; Rareș Crăciun; Iuliana Nenu; Adelina Horhat; Cristian Tefas; Zeno Spârchez; Cristina Adela Iuga; Tudor Mocan; Carmen Mihaela Mihu
Journal:  World J Gastroenterol       Date:  2022-04-21       Impact factor: 5.374

5.  A high level of integrin α6 expression in human intrahepatic cholangiocarcinoma cells is associated with a migratory and invasive phenotype.

Authors:  Yan-bing Ding; Bin Deng; You-sheng Huang; Wei-ming Xiao; Jian Wu; Yan-qing Zhang; Yuan-zhi Wang; Da-cheng Wu; Guo-tao Lu; Ke-yan Wu
Journal:  Dig Dis Sci       Date:  2013-01-11       Impact factor: 3.199

6.  Predicting peritumoral Glisson's sheath invasion of intrahepatic cholangiocarcinoma with preoperative CT imaging.

Authors:  Yingfan Mao; Yong Zhu; Yudong Qiu; Weiwei Kong; Liang Mao; Qun Zhou; Jun Chen; Jian He
Journal:  Quant Imaging Med Surg       Date:  2019-02

Review 7.  Cholangiocarcinoma.

Authors:  Samantha Sarcognato; Diana Sacchi; Matteo Fassan; Luca Fabris; Massimiliano Cadamuro; Giacomo Zanus; Ivana Cataldo; Paola Capelli; Francesca Baciorri; Matilde Cacciatore; Maria Guido
Journal:  Pathologica       Date:  2021-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.